Loading clinical trials...

Alcohol-ROC-Training | Clinical Trials | Clareo Health

RECRUITINGNA

Alcohol-ROC-Training

Brief Training for Heavy Drinking Young Adults: Regulation of Alcohol Craving

NCT05491551•Yale University

Summary

The goal of the proposed study is to examine whether brief training in regulation of craving (ROC-T) affects alcohol drinking. The study will consist of a basic screening (phone and online), and in person visit to determine eligibility and conduct pre-intervention baseline assessments, 1-4 training (ROC-T) visits, a post-intervention assessment visit, and 1-2 phone/online follow up assessments.The two active conditions of ROC-T are based on cognitive-behavioral treatments (CBT) and mindfulness-based treatments (MBT).

Detailed Description

This is a Stage 1B Randomized-Controlled Trial (RCT). 177 heavy drinking young adult participants will be randomized to 4 x 45-minute web-based sessions of (1) CBT-ROC-T training, (2) MBT-ROC-T, or (3) CONTROL (no strategy) delivered over three weeks. Participants will be enrolled for 16 weeks (three weeks pre-, three weeks during, and ten weeks post-intervention).

Eligibility

Age

18 - 26 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•(1) Young adults ages 18-26 years, who (2) report ≥ 3 heavy drinking days (i.e., heavy drinking defined by \>3 drinks for women, \>4 drinks for men) in the prior month; (3) are motivated to quit or reduce drinking; (4) are fluent in English and have a 6th grade or higher reading level; (5) have access to a computer with working internet; (6) use a working smartphone; (7) can commit to the full length of the protocol; and (8) are willing to be randomized to intervention condition.

Exclusion Criteria

•(1) Current (past 12 months) clinically-severe alcohol use disorder (AUD; e.g., history of seizures, delirium, or hallucinations during withdrawal) or current severe alcohol withdrawal; (2) Current (past 12 months) clinically-severe substance use disorder (except tobacco) or current severe drug withdrawal; (3) serious other psychiatric illness by history or examination; (4) severe or unstable physical disease within the past 6 months; (5) psychoactive medications (e.g., mood stabilizers) that have not been at a stable dose unless determined to be on a stable dose of medication by the study psychiatrist; (6) current use of any investigational medication; (7) color blindness; (8) biological females who are pregnant; and (9) notable dislike to any particular type of alcoholic beverage depicted in study stimuli; (10) Participants who will not complete at least 70% of past day EMA reports in the pre-intervention phase will not be randomized; (11) Participants who cannot understand or follow study-related instructions (e.g., unable to correctly use the intervention strategies, indicate lack of understanding of study instructions despite multiple attempts).

Locations (2)

University of California, Berkeley

Berkeley, California, United States

Yale University

New Haven, Connecticut, United States

Key Dates

Start Date

September 28, 2022

Primary Completion Date

December 1, 2027

Completion Date

December 1, 2027

Last Updated

February 19, 2026

Enrollment

177

ESTIMATED participants

Conditions

Binge DrinkingHeavy DrinkingYoung AdultHeavy Drinker

Interventions

Mindfulness-Based Treatment-Regulation of Craving

BEHAVIORAL

Cognitive-Based Therapy-Regulation of Craving

BEHAVIORAL

Contacts

Hedy Kober, PhD

CONTACT

917-470-8331 hedy.kober@yale.edu

Corey Roos

CONTACT

203-623-5882 corey.roos@yale.edu

Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors

NCT07471685

Cancer SurvivorshipFamily Planning+1 more

View study

RECRUITINGPHASE2

Orphan Indications for CD19 Redirected Autologous T Cells

NCT04276870

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALL+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 19, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Alcohol-ROC-Training

Inclusion Criteria

Exclusion Criteria

Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors

Orphan Indications for CD19 Redirected Autologous T Cells

Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

mHealth for Early Psychosis Caregivers in Statewide Program Outreach

Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention